Our results are consistent with other studies in which systemic Angpt2 administration has been shown to stimulate regression of neovascularisation10, 23, 24 and a previous study in which up-regulation of Angpt2 by systemic administration of an adenovirus vector inhibited atherosclerosis progression by 40%52. The gene discussed is ANGPT2; the disease is atherosclerosis.